Cite
99mTc-Tilmanocept performance for sentinel node mapping in breast cancer, melanoma, and head and neck cancer: a systematic review and meta-analysis from a European expert panel.
MLA
Rovera, Guido, et al. “99mTc-Tilmanocept Performance for Sentinel Node Mapping in Breast Cancer, Melanoma, and Head and Neck Cancer: A Systematic Review and Meta-Analysis from a European Expert Panel.” European Journal of Nuclear Medicine & Molecular Imaging, vol. 50, no. 11, Sept. 2023, pp. 3375–89. EBSCOhost, https://doi.org/10.1007/s00259-023-06290-5.
APA
Rovera, G., de Koster, E. J., Rufini, V., Zollino, M., Zagaria, L., Giammarile, F., Vidal-Sicart, S., Valdés Olmos, R., & Collarino, A. (2023). 99mTc-Tilmanocept performance for sentinel node mapping in breast cancer, melanoma, and head and neck cancer: a systematic review and meta-analysis from a European expert panel. European Journal of Nuclear Medicine & Molecular Imaging, 50(11), 3375–3389. https://doi.org/10.1007/s00259-023-06290-5
Chicago
Rovera, Guido, Elizabeth J. de Koster, Vittoria Rufini, Mariella Zollino, Luca Zagaria, Francesco Giammarile, Sergi Vidal-Sicart, Renato Valdés Olmos, and Angela Collarino. 2023. “99mTc-Tilmanocept Performance for Sentinel Node Mapping in Breast Cancer, Melanoma, and Head and Neck Cancer: A Systematic Review and Meta-Analysis from a European Expert Panel.” European Journal of Nuclear Medicine & Molecular Imaging 50 (11): 3375–89. doi:10.1007/s00259-023-06290-5.